Research theme for competitive and other funds (4):
1995 - がんの免疫療法に関する研究
1995 - Study on Tumor-immuro Therapy
がんの免疫療法に関する研究
Study on Cancer Immuro Therapy
MISC (49):
H Nishikawa, T Kato, K Tanida, A Hiasa, Tawara, I, H Ikeda, Y Ikarashi, H Wakasugi, M Kronenberg, T Nakayama, et al. CD4(+) CD25(+) T cells responding to serologically defined autoantigens suppress antitumor immune responses. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA. 2003. 100. 19. 10902-10906
H Nishikawa, T Kato, K Tanida, A Hiasa, Tawara, I, H Ikeda, Y Ikarashi, H Wakasugi, M Kronenberg, T Nakayama, et al. CD4(+) CD25(+) T cells responding to serologically defined autoantigens suppress antitumor immune responses. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA. 2003. 100. 19. 10902-10906
R Asada-Mikami, Y Heike, Y Harada, S Kanai, Y Ikarashi, K Kato, K Shirakawa, Y Takaue, T Abe, H Wakasugi. Increased expansion of V alpha 24(+) T cells derived from G-CSF-mobilized peripheral blood stem cells as compared to peripheral blood mononuclear cells following alpha-galactosylceramide stimulation. CANCER SCIENCE. 2003. 94. 4. 383-388
R Asada-Mikami, Y Heike, Y Harada, S Kanai, Y Ikarashi, K Kato, K Shirakawa, Y Takaue, T Abe, H Wakasugi. Increased expansion of V alpha 24(+) T cells derived from G-CSF-mobilized peripheral blood stem cells as compared to peripheral blood mononuclear cells following alpha-galactosylceramide stimulation. CANCER SCIENCE. 2003. 94. 4. 383-388